An index of insulin secretion in relation to insulin resistance (IS-SI) will be calculated Change in index from baseline at 32-36 weeks,at 56 -60 weeks, and at study end (80-84 weeks) [clinicaltrials_resource:c6a1cc3f3d1961b063d1db87c0e1881d]
β-cell compensatory capacity will be evaluated by the insulin sensitivity-secretion index (IS-SI) defined as the product of composite insulin sensitivity index and first-phase insulin release index (insulinogenic index).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
An index of insulin secretion in relation to insulin resistance (IS-SI) will be calculated Change in index from baseline at 32-36 weeks,at 56 -60 weeks, and at study end (80-84 weeks) [clinicaltrials_resource:c6a1cc3f3d1961b063d1db87c0e1881d]
β-cell compensatory capacity will be evaluated by the insulin sensitivity-secretion index (IS-SI) defined as the product of composite insulin sensitivity index and first-phase insulin release index (insulinogenic index).
Bio2RDF identifier
c6a1cc3f3d1961b063d1db87c0e1881d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c6a1cc3f3d1961b063d1db87c0e1881d
measure [clinicaltrials_vocabulary:measure]
An index of insulin secretion ...... nce (IS-SI) will be calculated
time frame [clinicaltrials_vocabulary:time-frame]
Change in index from baseline ...... nd at study end (80-84 weeks)
description
β-cell compensatory capacity w ...... e index (insulinogenic index).
identifier
clinicaltrials_resource:c6a1cc3f3d1961b063d1db87c0e1881d
title
An index of insulin secretion ...... nd at study end (80-84 weeks)
@en
type
label
An index of insulin secretion ...... 1cc3f3d1961b063d1db87c0e1881d]
@en